[Digestive adverse effects due to sodium polystyrene sulfonate (Kayexalate) in dialysis patients].
Administered to reduce hyperkaliema in patients with chronic renal failure, sodium polystyrene sulfonate (Kayexalate) can cause digestive complications. The most severe complication could be the intestinal necrosis or perforation. In the present report, we evoke these complications and illustrate them with some pictures from personal observations.
Montagnac
Richard
R
Service de nephrologie-hémodialyse, hôpital de Troyes, 101, avenue Anatole-France,10003 Troyes cedex, France. richard.montagnac@ch-troyes.fr
Méhaut
Sylvie
S
Schillinger
Francis
F
D006801:Humans; D007410:Intestinal Diseases / Q000139:chemically induced*; D011137:Polystyrenes / Q000009:adverse effects*; D006435:Renal Dialysis
D011137:Polystyrenes; C003321:polystyrene sulfonic acid